First cell treatment to fight the coronavirus awaits FDA approval for clinical trial
March 31, 2020 at 08:48 AM EDT
Therapeutics company Celularity is awaiting permission from the FDA to test whether a new cell therapy that boosts immunity could be effective against COVID-19. It has been used for cancer treatments.